GLP-1 study highlights movement and strength support during medical weight loss with Ozempic and Wegovy at Cosmetiq Medicine

New 2026 GLP-1 Study Shows Why Strength and Movement Still Matter During Weight Loss

A new GLP-1 study suggests that movement and strength support remain important during medical weight loss. Here’s what patients should know about staying active while using medications like Ozempic, Wegovy, Mounjaro and Zepbound.

New 2026 GLP-1 Study Shows Why Strength and Movement Still Matter During Weight Loss Read More »